MYLS22结构式
|
常用名 | MYLS22 | 英文名 | MYLS22 |
|---|---|---|---|---|
| CAS号 | 306959-01-3 | 分子量 | 443.52 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C24H21N5O2S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
MYLS22用途MYLS22 是首创的,选择性视神经萎缩 1 (OPA1) 抑制剂。MYLS22 可以靶向内皮细胞 OPA1 减少肿瘤的生长,通过影响 NFkB 活性和血管生成基因表达抑制血管生成。 |
| 英文名 | MYLS22 |
|---|---|
| 英文别名 | 更多 |
| 描述 | MYLS22 是首创的,选择性视神经萎缩 1 (OPA1) 抑制剂。MYLS22 可以靶向内皮细胞 OPA1 减少肿瘤的生长,通过影响 NFkB 活性和血管生成基因表达抑制血管生成。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
OPA1[1] |
| 体内研究 | MYLS22(10mg/kg/粒;瘤周注射;每2天一次,持续14天)导致肿瘤生长受限小鼠[1]。动物模型:6周龄C57BL6/J小鼠B16F10黑色素瘤[1]剂量:10mg/kg/滴注:瘤周注射;每2天一次,共14天结果:导致肿瘤生长受限。 |
| 参考文献 |
| 分子式 | C24H21N5O2S |
|---|---|
| 分子量 | 443.52 |
| InChIKey | WIEJADKUYLLKPX-UHFFFAOYSA-N |
| SMILES | Cc1nn(-c2ccccc2)c2sc(C(=O)Nc3c(C)n(C)n(-c4ccccc4)c3=O)cc12 |
| 储存条件 | 2-8°C,干燥,密封 |
| 危害码 (欧洲) | Xi |
|---|
|
实验名称:Dicer-mediated maturation of pre-microRNA
来源:Center for Chemical Genomics, University of Michigan
靶标:N/A
External Id:TargetID_659_CEMA
|
|
实验名称:Inhibitors of CDC25B-CDK2/CyclinA interaction
来源:Center for Chemical Genomics, University of Michigan
External Id:MScreen:TargetID_600
|
|
实验名称:Cell-based high throughput primary assay to identify activators of GPR151
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id:GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify activators of...
来源:The Scripps Research Institute Molecular Screening Center
靶标:N/A
External Id:FBW7_ACT_ALPHA_1536_1X%ACT PRUN
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
来源:The Scripps Research Institute Molecular Screening Center
External Id:MITF_INH_Alpha_1536_1X%INH PRUN
|
| MFCD01062681 |